Recombinant Hepatitis B Surface Antigen

Information about Recombinant Hepatitis B Surface Antigen

Recombinant hepatitis b surface antigen uses

Recombinant Hepatitis B Surface Antigen is used to prevent chronic hepatitis B virus (HBV) infection.

How recombinant hepatitis b surface antigen works

Recombinant Hepatitis B Surface Antigen is a vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.

Common side effects of recombinant hepatitis b surface antigen

Nausea, Neuropathy, Pain, Paralysis, Abdominal pain, Anaphylactic reaction, Angioedema (swelling of deeper layers of skin), Convulsion, Diarrhea, Dizziness, Fatigue, Fever, Headache, Decreased blood pressure, Itching, Feeling of discomfort, Meningitis, Muscle pain, Rash, Erythema (skin redness), Vomiting, Weakness

Available Medicine for Recombinant Hepatitis B Surface Antigen

Engerix-B
1 variant(s)

Expert advice for Recombinant Hepatitis B Surface Antigen

Recombinant Hepatitis B Surface Antigen helps prevent infections caused by Hepatitis-B Virus.
It is given by injection into a muscle by your doctor.
Inform your doctor if you or your child has an infection with fever as vaccination may need to be delayed until recovery.
It does not prevent infection by Hepatitis A, Hepatitis C, Hepatitis D, Hepatitis E or other pathogens that may infect the liver.